|Past two years||Past Year||Past 30 Days|
|Full Text Views||2||0||0|
A test system has been developed to evaluate the trypanosomicidal activity of large numbers of candidate drugs. Based on mortality of mice with blood induced Trypanosoma rhodesiense infections, it serves as a primary screen or as a secondary and confirmatory test for active compounds. Over 5,500 selected compounds have been tested; more than 6% were active.
This test system was developed by Dr. Leo Rane (before his sudden death on 21 June 1973). It is the last of several that he developed. Dr. Rane made the world a better place to live in for his fellowman. In recognition of this the words engraved upon the plaque that was unveiled at the dedication of the Leo Rane Laboratory say it very well—“In his test systems he attained an unprecedented level of precision and successfully demonstrated the scientific value and potential of basic chemotherapy research.” The continuation and close supervision of testing reported in this paper have been accomplished by Mrs. Leo Rane. The final compilation of information along with the writing presented herein were accomplished by Lieutenant Colonel Kenneth E. Kinnamon, Walter Reed Army Institute of Research, with the aid of Mrs. Rane.
Present address: Uniformed Services University of the Health Sciences, 6917 Arlington Road, Bethesda, Maryland 20014.